Cisplatin and doxorubicin for invasive basal cell carcinoma of the eyelids.

M. Neudorfer, O. Merimsky, M. Lazar, O. Geyer

Research output: Contribution to journalArticlepeer-review

Abstract

Cisplatin and doxorubicin were used in the treatment of recurrent invasive basal cell carcinoma (BCC) of the medial canthus and orbit. Complete remission was observed after treatment termination, and this was still evident five years later. Systemic chemotherapy offers an alternative mode of treatment for selected cases of advanced BCC.

Original languageEnglish
Pages (from-to)11-13
Number of pages3
JournalAnnals of Ophthalmology
Volume25
Issue number1
StatePublished - Jan 1993
Externally publishedYes

Fingerprint

Dive into the research topics of 'Cisplatin and doxorubicin for invasive basal cell carcinoma of the eyelids.'. Together they form a unique fingerprint.

Cite this